Article title: Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes
Authors: Rossing, P., Groehl, F., Mernagh, P., Folkerts, K., Garreta-Rufas, A., Harris, J., Meredith, K., Carter, M., Åkerborg, Ö., Wanner, C., & Richard Hobbs, F. D.
Journal: Journal of Medical Economics
Bibliometrics: Volume 26, Number 01, pages 935–943
DOI: https://doi.org/10.1080/13696998.2023.2235922
This article was first published online with the following errors. These errors have now been corrected and article has been re-published online.
Correction 1:
The Figure 2 was incorrect. The orange oval (second to left) in Figure 2 should read as “High CKD risk” not “Moderate CKD risk”.
Incorrect Figure 2: 
Updated Figure 2: 
Correction 2:
Table 2 – A new reference (see below) citation is added under the “Nephrologist visit”.
New reference: “National Health Service England. 2019/20 National Cost Collection Data Publication 2021. Available from: https://www.england.nhs.uk/publication/2019-20-national-cost-collection-data-publication/”.
Correction 3:
Table 3 – The text in the left column is updated as follows:
Table 3. Assumed relative risk reduction rates by treatment analyzed.